Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Trivano
Alles over “Diensten aan de gezondheidssector”
Aandelen in “Diensten aan de gezondheidssector”
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Aandeel
Datum
Koers
Evolutie
Even geduld...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Nieuws over “Diensten aan de gezondheidssector”
Toon enkel gratis nieuws
28/10 ·
Labcorp Announces 2025 Third Quarter Results
· Persbericht
28/10 ·
Labcorp Announces 2025 Third Quarter Results
· Persbericht
27/10 ·
New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis
· Persbericht
23/10 ·
Cegedim: like-for-like revenue growth of 2.1% over 9 months is on target
· Persbericht
23/10 ·
Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings
· Persbericht
21/10 ·
Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025
· Persbericht
15/10 ·
Mercy Earns National Honor for Excellence in Patient Experience
· Persbericht
10/10 ·
Cegedim: Release of its 2025 Interim Financial Report
· Persbericht
8/10 ·
Labcorp Declares Quarterly Dividend
· Persbericht
8/10 ·
Cegedim: Stacks selected to coordinate a new electronic medical record in the Balearic Islands
· Persbericht
6/10 ·
Cegedim: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
· Persbericht
30/09 ·
Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities
· Persbericht
26/09 ·
Equasens: 2025 half-year results
· Persbericht
25/09 ·
Labcorp to Announce Third Quarter Financial Results on October 28, 2025
· Persbericht
25/09 ·
Cegedim’s profitability improving as expected in H1 2025
· Persbericht
25/09 ·
Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025
· Persbericht
23/09 ·
Cegedim: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
· Persbericht
23/09 ·
Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration
· Persbericht
22/09 ·
Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer
· Persbericht
16/09 ·
Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference
· Persbericht
15/09 ·
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
· Persbericht
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe